Keyphrases
Fibrosis
100%
SIK2
100%
Bleomycin-induced Lung Injury
100%
Nintedanib
57%
Bleomycin-induced Pulmonary Fibrosis
42%
SIK3
42%
Idiopathic Pulmonary Fibrosis
28%
SIK1
28%
Lung Fibrosis
28%
Immune System
14%
Fibroblast Growth Factor Receptor 1 (FGFR1)
14%
Knock-in Mouse Model
14%
Platelet-derived Growth factor-BB (PDGF-BB)
14%
Putative Drug Targets
14%
Tyrosine Kinase
14%
IC50
14%
Vascular Endothelial Growth Factor
14%
Tyrosine Kinase Inhibitor
14%
Conditional Knockout
14%
Kinase Target
14%
Receptor Tyrosine Kinase
14%
Histological Score
14%
Fatal Infection
14%
Knock-in mutation
14%
Developmental Phenotype
14%
Limited Treatment Options
14%
Collagen Deposition
14%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Fibrosis
100%
Bleomycin-Induced Lung Injury
100%
Table Salt
100%
Nintedanib
50%
Protein Tyrosine Kinase
25%
Fibrosing Alveolitis
25%
Lung Fibrosis
25%
Bleomycin-Induced Pulmonary Fibrosis
25%
Disease
12%
IC50
12%
Knockout Mouse
12%
Platelet Derived Growth Factor
12%
Vasculotropin
12%
Fibroblast Growth Factor Receptor
12%
Bleomycin
12%
Protein Tyrosine Kinase Inhibitor
12%